During the past decade, Shanghai Pudong Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Pudong Hospital" #1 sponsor was "Shanghai Pudong Hospital" with 6 trials, followed by "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Chipscreen Biosciences, Ltd." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Pudong Hospital" #1 collaborator was "Shanghai Pudong Hospital" with 2 trials as a collaborator, "Shanghai Zhongshan Hospital" with 2 trials as a collaborator, "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Anhui Provincial Hospital" with 1 trials as a collaborator and "Baotou Central Hospital" with 1 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Pudong Hospital" are "COVID-19" (3 trials), "Acute Ischemic Stroke" (2 trials), "Type 2 Diabetes" (2 trials), "Atherosclerosis Obliterans" (1 trials) and "Carcinoma of the Rectum" (1 trials). Many other conditions were trialed in "Shanghai Pudong Hospital" in a lesser frequency.

Most popular intervention types in "Shanghai Pudong Hospital" are "Drug" (8 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Metformin Hydrochloride" (2 trials), "Alteplase" (1 trials), "Carotid endarterectomy (CEA)" (1 trials) and "Chiglitazar 32mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Pudong Hospital" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Shanghai Pudong Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Shanghai Pudong Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Pudong Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Shanghai Pudong Hospital has several departments that took part in Clinical trials: "Department of neurosurgery, Xuanwu hospital" - 5 trials, "Beijing Shunyi Hospital" - 3 trials, "Beijing You An Hospital; Digestive Dept" - 3 trials, "Gastroenterology" - 2 trials